GNH USA

Europe — EMA

[123i]-Mibg

Iodine (123I) Iobenguane, also known as [123I]-Mibg, is a radiopharmaceutical used in diagnostic imaging for neuroendocrine tumors. This non-invasive scan helps

Iodine (123i) Iobenguane

Request sourcing

1
Pack/s

What is Iodine (123i) Iobenguane?

Iodine (123I) Iobenguane, also known as [123I]-Mibg, is a radiopharmaceutical used in diagnostic imaging for neuroendocrine tumors. This non-invasive scan helps detect tumors like pheochromocytomas and neuroblastomas. Suitable for adults and children, it provides detailed internal images for accurate diagnosis. Always consult a healthcare provider for personalized guidance.

What is Iodine (123i) Iobenguane used for?

Iodine (123I) Iobenguane is primarily used in medical imaging to locate neuroendocrine tumors in the body. It helps identify conditions such as pheochromocytomas, neuroblastomas, and other related tumors. The radiopharmaceutical is administered intravenously and accumulates in tumor cells, making them visible on imaging scans. This diagnostic tool aids healthcare professionals in planning appropriate treatment strategies.

What are the side effects of Iodine (123i) Iobenguane?

After administration, Iodine (123I) Iobenguane travels through the bloodstream and is taken up by neuroendocrine cells, including those in tumors. The radioactive iodine emits gamma rays, which are detected by imaging equipment to create detailed pictures of the body's internal structures. Patients may experience mild discomfort at the injection site or temporary fatigue. The effects are temporary and resolve as the radiopharmaceutical is cleared from the body.

What precautions apply to Iodine (123i) Iobenguane?

This radiopharmaceutical should only be handled and administered by trained healthcare professionals in a controlled medical setting. Patients should inform their healthcare provider about any allergies, medications, or medical conditions before the procedure. Pregnant or breastfeeding individuals should avoid this imaging due to potential risks to the fetus or infant. Close contact with others should be minimized for a short period post-administration to limit radiation exposure.

What does Iodine (123i) Iobenguane interact with?

Certain medications, particularly those affecting the thyroid or nervous system, may interfere with the uptake of Iodine (123I) Iobenguane. Patients should disclose all prescription, over-the-counter, and herbal supplements to their healthcare provider. Avoid iodine-containing supplements or contrast agents near the time of the scan, as they can affect imaging results. Alcohol and specific foods may also impact the procedure, so follow pre-scan dietary guidelines provided by your doctor.

Frequently asked questions

What is Iodine (123I) Iobenguane used for?+
It is used in diagnostic imaging to detect neuroendocrine tumors such as pheochromocytomas and neuroblastomas.
How is Iodine (123I) Iobenguane administered?+
It is given as an intravenous injection in a clinical setting by healthcare professionals.
Are there side effects of Iodine (123I) Iobenguane?+
Mild effects may include discomfort at the injection site or temporary fatigue. Serious side effects are rare.
Can I drive after receiving Iodine (123I) Iobenguane?+
Patients should arrange for transportation home, as driving may not be advisable immediately after the procedure.
How long does the imaging procedure take?+
The scan typically takes 30 to 60 minutes, though preparation and observation may extend the visit.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Iodine (123i) Iobenguane
Route
Intravenous Use
Manufacturer
Curium Netherlands B.V.
Origin
EU

Related products